Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is not a sports team. We've been waiting for years while Missling drags his feet overpromising and underdelivering. There's no financial reward for you being a "true long", aka a pushover.
So basically Missling is just sitting on his hands waiting for the FDA to engage him? Why did he lie in December about "aggressively" approaching regulators? Does he understand what that word means?
I clicked on your article, ctrl+f Anavex and there were zero results. Seems desperate man...
Do the math... Either the interest isn't there or they're getting lowball offers.
Every group of investors on the internet is convinced there is a massive global campaign solely focused on their snowflake investment. Truly a fascinating phenomenon...
I wouldn't. You need data released first. The FDA isn't going to approve just because some dudes typed in all caps on message boards
Man the bar is set low when we're congratulating someone for only diluting "some". The ATM essentially has tempered every pump in share price. He also sold off shares in the middle of the year (so not for tax reasons) near all time highs and he gets awarded stock options for pennies on the dollar, so this is not a risky position for him that requires any conviction. Missling is already set for life $$ wise. It would have been nice if he bought some more shares during the '22 lows to bolster some confidence amongst investors. He could've certainly afforded it.
What is the latest with the PDD data? At this point I imagine he's just hoping shareholders forgot about it
What a nightmare. What is the exact holdup on the data? It really is going to be 2024 as I have been predicting.
Also zero update on "aggressive approval". They are always "planning" or "going to do" something, and it never materializes. Missling is a master of skirting SEC boundaries with his vague language. That's probably his best attribute now that I think about it.
I remember. Actually thinking back I can't ever remember him meeting one of his milestones on time.
It's such a lame dog and pony show. Why even bother with Q&A if it's not going to be genuine? Missling of course loves it. He doesn't have to answer any real questions, has his answers typed out before hand, and then can quickly get back to vacation after having accomplished another quarter of getting nothing done and getting paid a ton. Pretty sweet setup for "The Good Doctor".
Did the article say anything about when the data will be released? I ran out of free articles on SA. I think someone mentioned q3 2023, so in reality q2 2024 at the earliest.
"Flawless"... thanks for the laugh
Not sure why they all want a lawsuit similar to NWBO. All that would do is tie up AVXL's management with hours of legal bs. Could you imagine how ineffective they would be with all those distractions? They can't even get anything done without a lawsuit going on in the background.
Further, it would waste a bunch of the company's cash on legal fees. So they'd end up having to dilute shareholders. The fees would be enormous as the people they'd be suing have tremendous resources and would tie this up in court for years.
A) there's zero chance Missling will be working that close to a holiday. He typically takes a few months off every holiday to take a break from taking a break.
And B), you forgot in include the year, which will probably be 2024 given Missling's track record of missing every single deadline he's ever announced.
Exactly. We are now exactly 2 months after Missling's "aggressive approval" comments. CRICKETS.
Agreed. At this point, $10-15B is a pipe dream. This stock needs to be trading at like $50 or higher before those numbers could be considered.
You'll get used to seeing posts like that every week...for years. You probably already know better but definitely don't make investment decisions off of these. That comment was pure speculation. From the way a lot of people here type, you'd think they're on the golf course with Missling every weekend.
I'll bite... what's the news you're expecting "george"?
You know if this was baseball, your prediction average would be so low, you wouldn't get playing time on a little league team.
Is there going to be an announcement when someone starts writing the peer review article on the data?
Given Missling's track record, I think it's very likely it hasn't been started yet. His comments at JPM conference made it sound like data won't be released until the article is published. If that's the case, I wouldn't hold my breath on seeing data until q3 this year at the earliest. The nightmare continues
"Up so much" is an interesting way to put it. Short memories around here. We were at $15 before the CTAD disaster. This stock should be $30 minimum...$60 if the overall markets start to recover. And yet here we are, celebrating a few cents in premarket. Sad.
Can someone explain what is the actual hold up on releasing full data? Why can't the company at least give a timeline on when it will be released? Is there something outside of their power here at play?
You guys have been accumulating close to a decade now eh... Must be nice to have that much dry powder available to throw at this.
You realize Missling sold the highs in the middle of '21 right? Right in the middle of the year so no one can claim it was tax related either. He knew the stock was going down and unloaded before hand. This information is public.
Thanks for sharing. At the very least we CAN confirm Kun Jin is currently working at Anavex as VP of biostatistics and previously spent 27 years with the FDA. This is all verified from his Linkedin profile. Also a PHD in statistics from Berkeley. Promising...
Doc - I'd be interested to know if you still have a position here as well. I believe you said you sold prior to CTAD but can't remember exactly.
You realize he has gone after Cassava multiple times previously right? You know you can just google this stuff... It would be disingenuous to insinuate Cassava doesn't have their fair share of fudding, rightfully deserved or not is another question.
This SAVA ordeal is yet another shining example of how utterly incompetent Anavex management has been these past few years. It's like they've gone out of their way to make sure our valuation is horrific. SAVA has one drug that doesn't even work versus AVXL that has multiple indications and a better (or so they claim, STILL waiting on data) AD drug, and they are still valued 50% higher. It's truly unbelievable when you step back and look at it.
I think the same type scenario is going to play out with AVXL if/when Missling releases data. So by spring of '24 probably when he's done with his analysis.
I thought Missling was "aggressively" pursuing approval? Since you seem to know what's going on in the background, what tangible steps has he made since making that statement in early December?
Yeah you're right, we'll get data at the JPM conference on 1/12/23.... oh wait.
To translate for those who haven't been here long:
If Anavex/Missling says, then the reality is -->
-may ---> 0% chance of happening
-should --> 5% chance of happening
-will release in second half of the year --> they actually mean the next year
-we're working on --> we're thinking about starting soon
-aggressive approval --> do nothing and hope something good happens
-our results show "x" percentage --> that's a ballpark number but we don't have technology like calculators and excel sheets to confirm.
-peer review --> we'll get that high school science teacher from seeking alpha to write another article
And so on and so forth...
Is that standard practice for biotechs? Seems kind of shady they always remove.
So "aggressive" approval means there's going to be a long quiet period where nothing gets done? I think you guys need to revisit the word aggressive.
Man this is sad. A never ending cycle of moving the goalposts to the next "event'. So basically the entire 2023 is out as another dead year for stock price.
So what's your prediction on AVXL as in investment in '23, '24? I share your concerns in that last paragraph. The quotes by random president here, or doctor here, etc., are great and all, but we've had that stuff for years here and it does nothing for share price. We need actual execution at this point, not anecdotes.